Researchers have recently conducted two groundbreaking trials exploring whether a drug commonly used to treat HIV could also be effective in preventing infection. With around 40 million individuals currently living with HIV/AIDS globally, the potential impact of such a discovery could be revolutionary.
The drug in question, typically used as part of antiretroviral therapy for those already infected with HIV, has shown promising results when tested as a means of preventing the transmission of the virus. This development could potentially provide a new and effective method of reducing the spread of HIV/AIDS and ultimately saving lives.
The trials have sparked hope among healthcare professionals and public health officials, who are eager to find innovative ways to combat the HIV/AIDS epidemic. Success in utilizing this drug for prevention could lead to significant strides in reducing the global burden of the disease and improving overall public health.
As researchers continue to analyze the results of these trials, the possibility of this drug serving a dual purpose in both treating and preventing HIV infection remains an exciting prospect. With further research and development, it is hoped that this breakthrough could ultimately contribute to the goal of eradicating HIV/AIDS once and for all.
Watch the video by DW News
Video “Could a drug used to treat HIV also prevent infection? | DW News” was uploaded on 09/21/2024 to Youtube Channel DW News
We need this for Covid next.
Make a medicine that have to take once in a year. It would be more than enough.
that’s insane! science is wild
Very impressive every six months is a huge improvement…another 10 years hiv maybe completely curable
Bla bla bla. DW news 🎉🎉🎉
Under his eye
It was tested on africans
Good News
Damn science !! You are scary……👏
Science beach! 😂
Medical science FTW 😊
Prayers failed for 100 yrs 😂😂😂
Pre-exposure/post-exposure prophylaxis, this is nothing new
The company probably spent tens of millions of dollars to develop this drug, and hundreds of millions of dollars to develop a bunch of comparable drugs that failed. They can't just sell their successes at production cost and expect to stay in business to develop tomorrow's drugs. If this is going to be cheap and available then governments have to step in and fund it, like they did with COVID vaccines.
That said, it sounds like the company is considering an equitable pricing structure: selling it cheap to countries that would never cover the development costs anyway, so there's nothing to gain by withholding it.
ADIS don’t die of dyslexia
Watch Gilead stock price skyrocket.
Früher hätte die FDP für die Freiheit gestimmt. Heute ist die FDP nur noch eine ideologisch verblendete wirtschaftsliberal-radikale Partei, die ihre gesellschaftsliberalen Wurzeln komplett vergessen hat.
PEP/PrEP is nothing new
Let me guess – the drug was tested by the drug companies that’s going to make the profits and that’s why they said it was almost 100% effective. Two years after it’s on the market they’ll be saying it’s 20% effective at best.